Figure 2. Hematoxylin-eosin IHC staining of (A) well-differentiated PNET and (B) poorly-differentiated PNEC. This figure has been adapted from Archives of Pathology & Laboratory Medicine, Fang J. M. and Shi J., A clinicopathologic and molecular update of pancreatic neuroendocrine neoplasms with a focus on the new world health organization classification, 143 (11): 1317-1326. © 2019 (59).